Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GTLB✓SelectedUSD · GTLBGSK vs GTLB performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs GTLB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.0%
GTLB return
-52.8%
Excess return
+107.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGTLBExcessAlpha
1D-1.3%-0.2%-1.2%-1.3%
7D-3.1%-6.0%+2.8%-3.0%
30D-0.9%-16.5%+15.6%-0.5%
3M-4.2%+7.2%-11.4%-4.4%
6M-1.6%+77.4%-79.0%-3.0%
YTD+2.6%+18.6%-16.0%+2.1%
1Y+6.2%+0.5%+5.7%+6.2%
3Y+55.0%-4.9%+59.9%+53.4%
5Y+42.8%-61.5%+104.3%+37.9%
All+55.0%-52.8%+107.8%+50.0%

Cumulative growth

Daily Returns

Daily percentage return beside GTLB.

Daily Out/Under-Performance

Portfolio return minus GTLB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GTLB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GTLB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling